Metraipolis › archive › dc_fcbdc7c0931f

Research progress on recombinant NDV in cancer therapy — Europe PMC PMID:41479917

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41479917
DOI
10.3389/fimmu.2025.1735440
License (as archived)
solo-consultazione
Archived
2026-11-07T14:08:00.942Z
SHA-256 of the archived text
cc7887b1fd36c1c116f57b4dff1cfec9cbf4e118d7ecf0be715d80a294a548a8
Stable URL of this page
https://metraipolis.com/documento/dc_fcbdc7c0931f

How to cite

Research progress on recombinant NDV in cancer therapy — Europe PMC PMID:41479917 — Europe PMC (en), https://europepmc.org/article/MED/41479917 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fcbdc7c0931f (Metraipolis archive dc_fcbdc7c0931f, sha256 cc7887b1fd36c1c116f57b4dff1cfec9cbf4e118d7ecf0be715d80a294a548a8)
BibTeX
@misc{dcfcbdc7c0931f,
  title = {Research progress on recombinant NDV in cancer therapy — Europe PMC PMID:41479917},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41479917},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fcbdc7c0931f; sha256 cc7887b1fd36c1c116f57b4dff1cfec9cbf4e118d7ecf0be715d80a294a548a8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41479917. Agents can read the archived copy with the MCP tool read_document.